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1. Introduction 
The majority of patients who require intervention for coronary artery disease are adequately 
treated by percutaneous coronary interventions (PCI) or coronary artery bypass grafting 
(CABG). However, a major reason for failure of these treatments is their dependency on 
luminal size and coronary outflow. Methods stimulating myocardial angiogenesis and new 
vessel formation that are not dependent on vessel caliber therefore provide an important 
alternative means of treatment. Topical negative pressure (TNP) has been used in the 
treatment of chronic and problematic wounds since the beginning of the 1990´s, and has 
been shown to increase blood flow and stimulate angiogenesis in the underlying tissue. 
Because of TNP´s stimulating effect on blood flow and angiogenesis TNP has been tried to 
be applied directly onto the myocardium, referred to as myocardial topical negative 
pressure (MTNP) to increase myocardial blood flow and reduce myocardial ischemia, and 
reduce myocardial infarction (Lindstedt et al. 2008a, Lindstedt et al. 2008b, Lindstedt et al. 
2007c, Lindstedt et al. 2007a, Lindstedt et al. 2007b, Lindstedt et al. 2008c, Lindstedt et al. 
2008d).  
2. Development of the topical negative pressure technique 
Topical negative pressure (TNP) therapy (also called vacuum-assisted closure (VAC) 
therapy, vacuum sealing or vacuum therapy) has developed from the standard surgical 
procedure of vacuum-assisted drainage to remove blood or serous fluid from a wound or 
surgical site. In essence, the TNP technique is very simple. A piece of foam, with an open 
structure, is inserted into the wound cavity and a wound drain with lateral perforations is 
placed on top of it. The entire area is then covered with a transparent adhesive membrane, 
which is firmly secured to the healthy skin around the wound margin. When the exposed 
www.intechopen.com
 
Novel Strategies in Ischemic Heart Disease 
 
276 
end of the drain tube is connected to a vacuum source, fluid is drawn from the wound 
through the foam into a reservoir for subsequent disposal. The plastic membrane prevents 
the ingress of air and allows a partial vacuum to form within the wound, reducing its 
volume and facilitating the removal of fluid.  
The practice of exposing a wound to sub-atmospheric pressure for an extended period of 
time to promote healing was first described by Fleischmann et al. in 1993, following the 
successful use of this technique in 15 patients with open fractures. They reported that the 
treatment resulted in, “efficient cleaning and conditioning of the wound, with marked 
proliferation of granulation tissue”. No bone infections occurred in any of the patients, 
although one developed a soft tissue infection, which subsequently resolved with further 
treatment. In two further papers, Fleischmann and his colleagues described the treatment of 
25 patients with compartment syndromes of the lower limb and 313 patients with various 
types of acute and chronic infections. Further success with topical negative pressure 
treatment in Germany was reported by Muller following the treatment of 300 patients with 
infected wounds. 
In these early studies, negative pressure was achieved by the use of conventional methods 
such as wall suction equipment or surgical vacuum bottles. Both these systems are 
associated with practical problems in terms of the delivery, control and maintenance of the 
required levels of negative pressure, as discussed by Banwell et al. . In 1995, a commercial 
system for vacuum-assisted closure was introduced in the United States. This equipment, 
called the VAC®, was designed to overcome some of the problems described by Banwell. 
The heart of the system is a microprocessor-controlled vacuum unit that is capable of 
providing controlled levels of continuous or intermittent sub-atmospheric pressure ranging 
from -25 to -200 mmHg.  
In early studies no attempts were made to investigate the physiological mechanisms behind 
the observed clinical effects, or to determine the optimum level of pressure. A seminal study 
by Morykwas et al. addressed both these issues using a series of animal studies. Deep 
circular defects, 2.5 cm in diameter, produced on the backs of pigs were dressed with open-
cell polyurethane-ether foam with a pore size ranging from 400-600 µm. In the first series of 
experiments, a laser Doppler technique was used to measure blood flow in the 
subcutaneous tissue and muscles surrounding the wounds as these were exposed to 
increasing levels of negative pressure, applied both continuously and intermittently. Their 
results indicated that while an increase in blood flow equivalent to four times the baseline 
value occurred with a negative pressure of -125 mmHg, blood flow was inhibited by the 
application of negative pressures of -400 mmHg and above. A negative pressure of -125 
mmHg was therefore used in subsequent studies. The rate of granulation tissue production 
under negative pressure was determined using the same model by measuring the reduction 
in wound volume over time. Compared with control wounds dressed with saline-soaked 
gauze, significantly increased rates of granulation tissue formation were observed with the 
application of both continuous (63.3  26.1%) and intermittent (103% 35.3%) negative 
pressure.  
The observation that intermittent or cycled treatment appeared to be more effective than 
continuous therapy is interesting, although the reasons for this are not fully understood. 
Two possible explanations were advanced by Philbeck et al.. They suggested that 
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intermittent pressure application results in rhythmic perfusion of the tissue, which is 
maintained because the process of capillary autoregulation is not activated. They also 
suggested that as cells that are undergoing mitosis must go through a cycle of rest, cellular 
component production and division, constant stimulation may cause the cells to ‘ignore’ the 
stimulus. Intermittent stimulation allows the cells time to rest and prepare for the next cycle. 
For this reason, it has been suggested that cyclical negative pressure should be used 
clinically, although some authors suggest that this should follow a 48-hour period of 
continuous vacuum to bring about a rapid initial cleansing effect. Following these 
investigations, Morykwas and colleagues postulated that multiple mechanisms might be 
responsible for the effects observed. In particular, they suggested that the removal of 
interstitial fluid decreased localized oedema and increased blood flow, which in turn 
decreased bacterial levels in tissue. It has since been proposed that the application of sub-
atmospheric pressure produces mechanical deformation or stress within the tissue resulting 
in protein and matrix molecule synthesis and enhanced angiogenesis. Using the rabbit ear as 
a model, Fabian et al. provided further evidence of the stimulatory effects of sub-
atmospheric pressure on the production of granulation tissue, and also demonstrated a 
trend towards enhanced epithelialisation. In experimental partial-thickness burns in pigs, 
sub-atmospheric pressure was shown to prevent progressive tissue damage in the zone of 
stasis that surrounds the area of the initial injury. This effect was demonstrable within 12 
hours of injury, with treatment times as short as six hours being sufficient to exert a 
measurable effect. The authors proposed that the removal of oedema fluid, containing 
suspended cellular debris, osmotically active molecules and biochemical mediators released 
following the initial injury, may lessen the obstruction of blood flow.  
Numerous other papers have described the use of TNP in the treatment of a variety of 
wound types, including extensive degloving injuries, infected sternotomy wounds and 
various soft tissue injuries prior to surgical closure, and in burn wound management. 
3. Physiological basis of TNP 
Numerous theories have been advanced to explain the physiological basis of the marked 
improvement in clinical outcomes achieved with TNP. Two basic, broad mechanisms have 
been proposed to account for the increased rate of granulation tissue formation and 
accelerated healing rate: a fluid-based mechanism and a mechanical mechanism. 
Application of a controlled vacuum to the wound interface facilitates the removal of excess 
interstitial fluid due to the higher pressure gradient. This physically results in a decrease in 
interstitial pressure. When the interstitial pressure falls below the capillary pressure, the 
capillaries reopen and flow to the periwound tissue is restored. This same mechanism is 
responsible for the success of the vacuum technique for decompression of both muscle 
compartment and abdominal compartment syndrome. All non-bound soluble factors will 
also be removed with the fluid, including inhibiting factors and promoting factors. 
Numerous descriptions have been presented of the change in concentration of various 
factors over time. Factors measured range from growth factors to metalloproteinases to C-
reactive protein. The interactions between the soluble factors related to wound healing, and 
also those factors and interactions that inhibit or delay healing, are extremely complex. The 
same factor can both promote and inhibit wound healing, depending on the concentration 
and timing during the healing process. Moreover, the negative pressure and increase in 
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blood flow to the wound bed have been shown to accelerate the formation of granulation 
tissue. Interestingly, intermittent application of sub-atmospheric pressure has produced 
superior results, possibly due to mitigation of the cellular desensitization that occurs with 
exposure to continuous sub-atmospheric pressure. Although it is likely that each of these 
factors plays a role in the action of TNP, the application of mechanical forces to the wound 
site is probably the most significant mechanism of action. 
Mechanical force is known to be responsible for the induction of cell proliferation and 
division. Plastic surgeons use tissue expansion to obtain soft-tissue envelopes in 
reconstructive surgery, while orthopaedic surgeons and maxillofacial surgeons use 
distraction osteogenesis to lengthen bones. Ingber et al. have shown that for cells to respond 
to soluble mitogenic factors and proliferate, they must be extended, leading to isometric 
tension, either by adherence to a stiff substrate or by external application of mechanical 
forces. Only stretched cells can divide and proliferate in response to soluble growth factors, 
whereas cells that are not stretched and assume a more spherical shape are cell-cycle 
arrested and tend to undergo apoptosis. It has also been shown in vitro that directional 
growth of capillary sprouts is promoted by the application of tension in three-dimensional 
angiogenesis models. The applied forces deform the extracellular matrix and, as cells are 
anchorage-dependent, the cells in the stretched tissue are deformed. Cell deformation has 
been shown to cause a wide variety of molecular responses, including changes in ion 
concentration and permeability of membrane ion channels, release of secondary messengers, 
stimulation of molecular pathways, and alterations in gene expression. Moreover, it is 
known that vascular endothelial cells express a different array of genes depending on 
whether they have been exposed to static, laminar or turbulent flow. It is apparent that cells 
are able to sense mechanical forces and respond through the regulation of specific genes and 
the induction of cellular programs. The exact mechanisms behind these effects are not fully 
understood, but are probably related to conformational changes in the cytoskeleton in 
response to mechanical forces. This behavior provides a natural mechanism for tissue 
homeostasis, where tissue mass expands, cells are stretched and are thus stimulated to 
divide. 
The application of negative pressure may promote wound angiogenesis by directly 
stimulating endothelial cells. For example, the application of TNP may cause local wound 
hypoxia, which is a potent stimulator of vascular endothelial growth factor (VEGF) 
production, the major endothelial cell mitogen. Alternatively, TNP may activate signal 
transduction pathways leading to endothelial cell division and growth factor production 
since endothelial tension causes capillary sprouting, gene expression, and changes in matrix 
metalloproteinase (MMP) activity. While TNP may directly stimulate endothelial 
proliferation by local hypoxia or cell deformation, increased wound angiogenesis may be an 
indirect effect of the TNP-mediated reduction in MMP activity. Although low levels of 
MMPs have been shown to favour angiogenesis, elevated MMP activity inhibits 
neovascularization and is associated with chronic wounds. Specifically, the levels of the 
gelatinases MMP-9 and MMP-2 are significantly higher in nonhealing wounds, but return to 
normal as wound healing progresses towards closure. In addition, chronic wound exudates 
that inhibit endothelial activity will instead stimulate angiogenesis after treatment with an 
MMP inhibitor. A reduction in MMP activity may promote endothelial proliferation by 
lowering MMP-mediated angiostatin and endostatin production. Alternatively, the 
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inhibition of a MMP-propagated inflammatory cascade may provide an environment more 
favorable to capillary growth. 
Mechanical properties seem to have a greater influence on clinical efficacy than fluid-based 
properties, according to a recently published article, in which the authors showed that the 
application of mechanical shear stresses was able to activate the VEGF pathway without any 
VEGF being present in the culture fluid  
4. Application of TNP directly onto the myocardium 
It was first described by Lindstedt et al that application of a negative pressure directly onto 
the myocardium resulted in an increase in blood flow in the underlying myocardium. In this 
first study microvascular blood flow in the myocardium was measured by laser Doppler 
flowmetry (LDF). The LDF probes were located 5-6 mm lateral to the middle part of the left 
anterior descending (LAD) , 5-6 mm down into the myocardial wall, and measurements 
were made before and after application of a MTNP of -50 mmHg. A significant increase was 
seen in all the animals when the myocardium was exposed to MTNP of -50 mmHg. The 
increase in blood flow was seen both in non-ischaemic myocardium (normal myocardium), 
in ischemic myocardium (after 20 minutes of LAD occlusion), and also in reperfused 
myocardium (formerly ischaemic myocardium after 20 minutes of reperfusion). In all the 
settings the increase in microvascular blood flow appeared immediately when MTNP was 
applied. In another study myocardial blood flow was measured using ultrasonic flow meter 
probes at the proximal part of the left anterior descending artery (LAD), the circumflex 
coronary artery (CCX) and the right coronary artery (RCA), before and after application of 
MTNP of -50 mmHg. Measurements were performed during normal conditions (non 
ischemic) and after occlusion of the LAD, i.e. ischemic conditions. The results implying that 
MTNP increases the total amount of coronary blood flow to the myocardium. Interestingly, an 
increase in myocardial perfusion measured by LDF, when the MTNP was applied, correlated 
to an increase in coronary blood flow in every animal. A non-uniform or a decrease in the total 
coronary blood flow might hypothetically cause ischemia in parts of the myocardium not 
exposed to MTNP. Since the present results shows a significant increase in the total amount of 
coronary blood flow, the authors believe that ischemic areas are not likely to occur. However, 
local effects in the myocardium could not be deduced from the study. 
When applying different negative pressures to periwound tissues (skeletal muscle and 
subcutaneous tissue) may causes different changes in blood flow. When the negative 
pressure exceeds a specific level it seems to constringe the vessels in periwound tissue and a 
decrease in local blood flow is seen. Morykwas et al has previously reported that the 
microvascular blood flow to a wound increased to four times the baseline value when a 
negative pressure of 125 mm Hg was applied, whereas it was inhibited at negative pressures 
of 400 mm Hg and above. The changes in blood flow is thought to be related to local effects, 
since the blood flow at a distance of 4.5 cm from the wound edge was not affected by the 
negative pressure between -50 and -200 mmHg. A zone of relative hypoperfusion has been 
observed close to the wound edge. Hypoperfusion induced by TNP is thought to depend on 
tissue density, distance from the negative pressure source, and the amount negative 
pressure applied. In the myocardium, however, MTNP between -25 and -50 mmHg have 
been shown to induce a significant increase in blood flow, whereas MTNP between -75 and -
150 mmHg have not been shown to induce any significant blood flow changes in the 
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underlying myocardium. The differences in blood flow pattern between periwound tissue 
and myocardium might be due to the differences in tissue histology, where the myocardium 
has a higher density than periwound tissue. The absence of increase in blood flow when the 
myocardium is exposed to pressures between -75 and -150 mmHg might, in part be due to, 
counteract forces. Hypothetic pressures above -150 mmHg might have led to constringe of 
the vessels, thus reducing the microvascular blood flow to the exposed myocardium. In a 
study, comparing the two negative pressures -25 and -50 mmHg, both pressures resulted in 
a significant increase in myocardial blood flow, and no significant difference could be 
observed between the two pressures.  However, the increase in blood flow was greater in 
normal myocardium when the pressure of -25 mmHg was used. Furthermore, in ischemic 
myocardium the increase was greater when using -50 mmHg. The study, however, only 
contained six animals, and the difference might have been significant in a larger study. The 
authors believe that the optimal MTNP in clinical perspective might be -50 mmHg, since 
ischemic conditions would be of greater interest than normal. 
As earlier mentioned, a zone of relative hypoperfusion has been observed in studies when 
TNP is applied on wounds. The zone of hypoperfusion is believed to appear close to the 
negative pressure source. When MTNP, a large zone of hypoperfusion, would theoretically 
cause ischemia in the epicardium that would theoretically cause ischemia. In wound healing 
the effect of hypoperfusion or ischemia close to the negative pressure source might be 
beneficial to wound healing, since hypoxia has been shown to be a strong factor for 
stimulating VEGF and new vessel formation. In MTNP however, a zone of hypoperfusion 
would probably not be desirable. Interestingly, three different studies on animals have 
shown a significant increase in epicardial blood flow when exposed to MTNP of -50mmHg. 
MTNP between -75 and -150mmHg did not; in any of the studies induce a significant change 
in myocardial blood flow. Probably because the amount of negative pressure applied is to 
large, resulting in an obstruction of the vessels. Consequently, no hypoperfusion could be 
observed during MTNP in either normal, ischemic, or reperfused myocardium during both 
normo- and hypo-thermia. The absence of hypoperfusion could possibly be explained by the 
higher density of myocardium than wound tissue. It could however also possibly be 
explained by the release of vasodilators close to the negative pressure source. Another 
possible explanation is that the increase in blood flow is due to a redistribution of the 
microvascular blood flow to the epicardium caused by natural physiological microvascular 
mechanisms in the myocardial wall, as seen during for example systolic blood pressure 
below 50 mmHg. Another possible explanation is that the negative force is greater closer to 
the vacuum source and subsequently decreases with distance.  
Argenta et al. investigated in 2010 if MTNP applied onto the myocardium followed acute 
myocardial infarction could decrease the size of myocardial infarction in an animal model. 
They induce ischemia by 75 minutes of left main coronary artery occlusion and thereafter 
three hours of reperfusion. Animals were assigned to one of three groups: (A) untreated 
control; treatment of involved myocardium for 180 minutes of MTNP with (B) -50 mmHg, or 
(C) -125 mmHg. Treatment of the ischemic area with MTNP for 180 minutes significantly 
reduced infarct size (area of necrosis/area at risk) in both treatment groups compared to 
control. Total area of cell death was reduced by 65% with -50 mmHg treatment and 55% in 
the -125 mmHg group. They concluded that treatment of ischemic myocardium with MTR, 
for a controlled period of time during reperfusion, successfully reduced the extent of 
myocardial death after acute myocardial infarction. 
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5. Ischemic heart disease; clinical application of TNP 
The majority of patients who require intervention for coronary artery disease are adequately 
treated by PCI or CABG. However, a major reason for failure of these treatments is their 
dependency on luminal size and coronary outflow. Methods of stimulating new vessel 
formation in the myocardium that are not dependent on vessel caliber therefore provide an 
important alternative treatment. A large group of patients suffer from refractory angina 
pectoris. Conventional treatment such as PCI and CABG has not been successful in these 
patients. Various other therapies have been tried, such as percutaneous myocardial laser 
revascularization, and enhanced external counter-pulsation, with varying success. Even 
spinal cord stimulation has been used in an attempt to ease their ischaemic pain. However, a 
satisfactory means of treating these patients has yet to be found. A new form of treatment 
resulting in new collateral vessel formation would thus be of interest for these patients.  
Numerous studies have evaluated the efficacy of gene therapy in the treatment of ischemic 
heart disease for the restoration of myocardial function by stimulation of angiogenesis and 
collateral vessel formation. VEGF has been found to be one of the most interesting growth 
factors in therapeutic angiogenesis. Interestingly, the mechanical forces exerted by TNP 
stimulate the endogenous production of VEGF. 
In patients with acute coronary syndrome and coronary vessel occlusion, it is of great 
importance to improve or, if possible, restore the blood flow to the ischemic myocardium to 
protect it from ischemic stress and, in some cases, acute coronary infarction. Most patients 
are successfully treated with conventional methods such as PCI or CABG. However, these 
procedures do not result in satisfactory results in all patients due to extensive coronary 
disease or small vessel caliber. Furthermore, the procedure is not suitable for some patients 
due to their advanced age, renal failure, or other complicating factors. In some cases of acute 
ST elevation myocardial infarction there is no reflow during PCI. No-reflow situations may 
also arise during saphenous vein graft intervention, and rotational atherectomy. During no-
reflow, epicardial flow is reduced due to obstructions at the microvasculature level. This no-
reflow condition is usually transient, but patients with refractory no-reflow are associated 
with a markedly increased risk of 30-day mortality, compared with patients in whom no-
reflow is transient. MTNP of -50 mmHg significantly increased the microvascular blood 
flow in both the epicardium and the myocardium. Interestingly, MTNP increases both the 
velocity and volume of blood flow by opening up the capillary beds. Furthermore, the 
method is not dependent on vessel caliber. 
6. Conclusion 
In conclusion, MTNP increases blood flow to the heart during normal, ischemic and 
reperfused conditions during both normo- and hypo-thermia. Interestingly, MTNP increases 
blood flow both in the endocardium and in the epicardium of the myocardial wall. The 
authors believe that MTNP may in the future represent an alternative treatment for patients 
with coronary artery disease and in particular patients with refractory angina pectoris. 
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